Stockreport

Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference

Lexeo Therapeutics, Inc.  (LXEO) 
PDF NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatment [Read more]